Structure of the mouse cytoplasmic lattice
Nature, Published online: 31 March 2026; doi:10.1038/s41586-026-10442-6
Structure of the mouse cytoplasmic latticeNature, Published online: 31 March 2026; doi:10.1038/s41586-026-10442-6
Structure of the mouse cytoplasmic latticeCurr Med Chem. 2026 Mar 17. doi: 10.2174/0109298673415187251212085809. Online ahead of print.
ABSTRACT
BACKGROUND: Solanum incanum L. (S. incanum) is a Traditional Chinese Medicine (TCM) known for its heat-clearing and detoxifying properties. This study evaluates the anti-cancer potential of S. incanum in lung and colorectal adenocarcinoma. Also, we aim to confirm the connection between the lung and the large intestine, as proposed in TCM theory.
METHODS: This study employed network pharmacology analysis, MTT and morphological analysis, Western blotting, and molecular docking to investigate the anti-cancer effects of S. incanum, particularly through its activation of the TRAIL-mediated extrinsic apoptotic pathway.
RESULTS: This study identified 15 active compounds in S. incanum, with glycosylated alkaloids such as α-solanine and solasonine highlighted as key bioactive compounds. KEGG and GO analyses revealed that S. incanum influences apoptosis-related pathways, particularly the extrinsic apoptotic pathway, regulating mediators such as CASP3, CASP8, and various TNF- related receptors. The anticancer potential was assessed through cellular studies using A549 and HT29 cell lines, with MTT cell viability assays showing that α-solanine induces apoptosis, with IC50 values between 20 and 30 μM. Western blot analysis demonstrated that S. incanum activates apoptosis via the TRAIL-mediated extrinsic apoptotic pathway, promoting CASP8, CASP3, and PARP1 cleavage in a dose-dependent manner, affecting DNA synthesis. Molecular docking further identified α-solanine and solasonine as compounds that bind to critical proteins in the TRAIL-related apoptotic pathway, confirming their roles in promoting apoptosis.
DISCUSSION: The shared activation of the TRAIL-mediated apoptotic pathway in both lung and colorectal adenocarcinoma models suggests a common molecular mechanism. These findings provide experimental evidence linking traditional ethnopharmacological concepts with apoptosis-related anti-cancer activity.
CONCLUSIONS: This study emphasizes that the main compound of S. incanum, α-solanine, supports the ethnopharmacological concept of "Exterior-interior Pairing of the Lung and Large Intestine", thereby demonstrating that both lung and colorectal adenocarcinomas share a common anticancer pathway through a TRAIL-related apoptotic mechanism.
PMID:41863159 | DOI:10.2174/0109298673415187251212085809
Am J Surg Pathol. 2026 Jun 1;50(6):695-704. doi: 10.1097/PAS.0000000000002533. Epub 2026 Mar 13.
ABSTRACT
With the application of molecular techniques in pathologic diagnosis, several novel primary pulmonary epithelial tumors have been continuously discovered and classified under the WHO classification of thoracic tumors. Recently, a pulmonary tumor with NFATC2 :: NUTM2B fusion was first documented, but the spectrum of NFATC2::NUTM2 fusion variants and their associated pathologic features remains incompletely characterized. Coincidentally, we also found and described 6 primary pulmonary tumors harboring recurrent NFATC2::NUTM2A/E fusions through integrated genomic analysis. These patients, including 4 females and 2 males, with a median age of 53 years, presented with incidentally detected peripheral lung nodules composed of monotonous epithelioid cells arranged in cords, nests, and trabeculae within a prominent desmoplastic stroma. All tumors exhibited a consistent immunophenotype: CK5/6+/GATA3+/calponin+/EMA+/DOG1 (perinuclear dot-like staining)/p63-. High-throughput chromosome conformation capture (Hi-C) analysis showed the structural variation of NFATC2::NUTM2E in all 6 cases, whereas RNA sequencing detected the fusion transcripts in 5 cases ( NFATC2::NUTM2A , n=2; NFATC2::NUTM2E , n=3). Ultrastructural examination of 1 case suggested epithelial differentiation. All patients remained disease-free after complete resection (median follow-up: 24 mo; range: 9 to 41 mo). These findings define a novel primary pulmonary tumor entity driven by NFATC2::NUTM2 fusions, and characterized by a distinctive immunophenotype, expanding the spectrum of NUTM2 -associated neoplasms. Our study underscores the utility of multiomics approaches for characterizing rare neoplasms and provides a diagnostic framework for this entity.
PMID:41821426 | DOI:10.1097/PAS.0000000000002533
Am J Surg Pathol. 2026 Mar 13. doi: 10.1097/PAS.0000000000002533. Online ahead of print.
ABSTRACT
With the application of molecular techniques in pathologic diagnosis, several novel primary pulmonary epithelial tumors have been continuously discovered and classified under the WHO classification of thoracic tumors. Recently, a pulmonary tumor with NFATC2::NUTM2B fusion was first documented, but the spectrum of NFATC2::NUTM2 fusion variants and their associated pathologic features remains incompletely characterized. Coincidentally, we also found and described 6 primary pulmonary tumors harboring recurrent NFATC2::NUTM2A/E fusions through integrated genomic analysis. These patients, including 4 females and 2 males, with a median age of 53 years, presented with incidentally detected peripheral lung nodules composed of monotonous epithelioid cells arranged in cords, nests, and trabeculae within a prominent desmoplastic stroma. All tumors exhibited a consistent immunophenotype: CK5/6+/GATA3+/calponin+/EMA+/DOG1 (perinuclear dot-like staining)/p63-. High-throughput chromosome conformation capture (Hi-C) analysis showed the structural variation of NFATC2::NUTM2E in all 6 cases, whereas RNA sequencing detected the fusion transcripts in 5 cases (NFATC2::NUTM2A, n=2; NFATC2::NUTM2E, n=3). Ultrastructural examination of 1 case suggested epithelial differentiation. All patients remained disease-free after complete resection (median follow-up: 24 mo; range: 9 to 41 mo). These findings define a novel primary pulmonary tumor entity driven by NFATC2::NUTM2 fusions, and characterized by a distinctive immunophenotype, expanding the spectrum of NUTM2-associated neoplasms. Our study underscores the utility of multiomics approaches for characterizing rare neoplasms and provides a diagnostic framework for this entity.
PMID:41821426 | DOI:10.1097/PAS.0000000000002533